Copyright
©The Author(s) 2025.
World J Gastroenterol. Jan 21, 2025; 31(3): 95207
Published online Jan 21, 2025. doi: 10.3748/wjg.v31.i3.95207
Published online Jan 21, 2025. doi: 10.3748/wjg.v31.i3.95207
Figure 4 Identification of miRNA candidates.
A: Gene regulatory network showing miRNA-mRNA target predictions in HepG2 cells; B: SNU449 cells treated with Sorafenib for 24 hours; C: Heatmap of selected miRNAs.
- Citation: de la Cruz-Ojeda P, Parras-Martínez E, Rey-Pérez R, Muntané J. In silico analysis of lncRNA-miRNA-mRNA signatures related to Sorafenib effectiveness in liver cancer cells. World J Gastroenterol 2025; 31(3): 95207
- URL: https://www.wjgnet.com/1007-9327/full/v31/i3/95207.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i3.95207